Your browser doesn't support javascript.
loading
'Stealth' corporate innovation: an emerging threat for therapeutic drug development.
Mastellos, Dimitrios C; Blom, Anna M; Connolly, E Sander; Daha, Mohamed R; Geisbrecht, Brian V; Ghebrehiwet, Berhane; Gros, Piet; Hajishengallis, George; Holers, V Michael; Huber-Lang, Markus; Kinoshita, Taroh; Mollnes, Tom E; Montgomery, Robert A; Morgan, B Paul; Nilsson, Bo; Pio, Ruben; Ricklin, Daniel; Risitano, Antonio M; Taylor, Ronald P; Mantovani, Alberto; Ioannidis, John P A; Lambris, John D.
Affiliation
  • Mastellos DC; National Center for Scientific Research 'Demokritos', Aghia Paraskevi, Athens, Greece.
  • Blom AM; Department of Translational Medicine, Lund University, Lund, Sweden.
  • Connolly ES; Department of Neurological Surgery, Columbia University, New York, NY, USA.
  • Daha MR; Leiden University Medical Center, Leiden, Netherlands.
  • Geisbrecht BV; Department of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS, USA.
  • Ghebrehiwet B; Department of Medicine, Division of Rheumatology, Allergy and Immunology, Stony Brook University, New York, NY, USA.
  • Gros P; Department of Chemistry, Faculty of Science, Utrecht University, Utrecht, Netherlands.
  • Hajishengallis G; Department of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Holers VM; Division of Rheumatology, Departments of Medicine and Immunology, University of Colorado School of Medicine, Denver, CO, USA.
  • Huber-Lang M; Institute of Clinical and Experimental Trauma immunology, University of Ulm, Ulm, Germany.
  • Kinoshita T; Research Institute for Microbial Diseases Osaka University and Laboratory of Immunoglycobiology, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Mollnes TE; Department of Immunology, Oslo University Hospital, and University of Oslo, Oslo, Norway.
  • Montgomery RA; Research Laboratory, Nordland Hospital, Bodø, and K.G. Jebsen TREC, University of Tromsø, Tromsø, Norway.
  • Morgan BP; Centre of Molecular Inflammatory Research, NTNU, Trondheim, Norway.
  • Nilsson B; Department of Surgery, NYU Langone Transplant Institute, New York, NY, USA.
  • Pio R; Systems Immunity Research Institute, School of Medicine, Cardiff University, Cardiff, UK.
  • Ricklin D; Division of Clinical Immunology, Uppsala University Hospital, Uppsala, Sweden.
  • Risitano AM; Program in Solid Tumors, Center for Applied Medical Research (CIMA), University of Navarra, IDISNA, CIBERONC, Pamplona, Spain.
  • Taylor RP; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
  • Mantovani A; Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.
  • Ioannidis JPA; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA.
  • Lambris JD; Istituto Clinico Humanitas, Humanitas University, Milan, Italy.
Nat Immunol ; 20(11): 1409-1413, 2019 11.
Article in En | MEDLINE | ID: mdl-31562490
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Year: 2019 Type: Article